DAVENPORT & Co LLC decreased its position in Aetna Inc (NYSE:AET) by 21.6% during the 4th quarter, Holdings Channel reports. The firm owned 5,083 shares of the company’s stock after selling 1,397 shares during the period. DAVENPORT & Co LLC’s holdings in Aetna were worth $917,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors have also recently bought and sold shares of the stock. Koshinski Asset Management Inc. raised its holdings in Aetna by 22.6% during the 4th quarter. Koshinski Asset Management Inc. now owns 10,885 shares of the company’s stock valued at $1,964,000 after acquiring an additional 2,005 shares during the period. Creative Planning raised its holdings in Aetna by 9.2% during the 4th quarter. Creative Planning now owns 19,748 shares of the company’s stock valued at $3,562,000 after acquiring an additional 1,666 shares during the period. Gateway Investment Advisers LLC increased its holdings in shares of Aetna by 0.7% in the fourth quarter. Gateway Investment Advisers LLC now owns 299,902 shares of the company’s stock worth $54,099,000 after purchasing an additional 1,975 shares during the period. CHICAGO TRUST Co NA increased its holdings in shares of Aetna by 6.0% in the fourth quarter. CHICAGO TRUST Co NA now owns 16,726 shares of the company’s stock worth $3,018,000 after purchasing an additional 949 shares during the period. Finally, City Holding Co. increased its holdings in shares of Aetna by 23.8% in the fourth quarter. City Holding Co. now owns 2,760 shares of the company’s stock worth $498,000 after purchasing an additional 530 shares during the period. Institutional investors and hedge funds own 87.69% of the company’s stock.
Several research firms have recently weighed in on AET. Piper Jaffray Companies raised shares of Aetna from a “neutral” rating to an “overweight” rating and set a $136.00 price target on the stock in a report on Wednesday, January 3rd. Wells Fargo & Co reiterated an “outperform” rating and issued a $208.00 target price (up from $200.00) on shares of Aetna in a research report on Monday, December 4th. Morgan Stanley lowered shares of Aetna from an “overweight” rating to an “equal weight” rating and set a $179.00 target price for the company. in a research report on Wednesday, December 20th. ValuEngine upgraded shares of Aetna from a “hold” rating to a “buy” rating in a research report on Sunday, December 31st. Finally, Credit Suisse Group assumed coverage on shares of Aetna in a research report on Thursday, November 2nd. They issued a “neutral” rating and a $174.00 target price for the company. Twelve research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company’s stock. The company presently has an average rating of “Buy” and a consensus target price of $172.64.
Aetna (NYSE:AET) last posted its earnings results on Tuesday, October 31st. The company reported $2.45 earnings per share for the quarter, topping the Zacks’ consensus estimate of $2.06 by $0.39. The company had revenue of $14.99 billion during the quarter, compared to analyst estimates of $15.12 billion. Aetna had a net margin of 2.93% and a return on equity of 21.84%. Aetna’s revenue for the quarter was down 5.0% on a year-over-year basis. During the same period in the prior year, the business posted $2.07 earnings per share. sell-side analysts anticipate that Aetna Inc will post 9.78 earnings per share for the current year.
The business also recently declared a quarterly dividend, which will be paid on Friday, January 26th. Investors of record on Thursday, January 11th will be paid a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a yield of 1.08%. The ex-dividend date of this dividend is Wednesday, January 10th. Aetna’s payout ratio is currently 36.97%.
TRADEMARK VIOLATION WARNING: “Aetna Inc (AET) Shares Sold by DAVENPORT & Co LLC” was first published by Ticker Report and is the sole property of of Ticker Report. If you are reading this news story on another publication, it was copied illegally and reposted in violation of United States & international copyright and trademark laws. The legal version of this news story can be viewed at https://www.tickerreport.com/banking-finance/3142812/aetna-inc-aet-shares-sold-by-davenport-co-llc.html.
Aetna Company Profile
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.
Want to see what other hedge funds are holding AET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aetna Inc (NYSE:AET).
Receive News & Ratings for Aetna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna and related companies with MarketBeat.com's FREE daily email newsletter.